Bayer restructuring

Bayer announced last week that it will close its hemophilia manufacturing facility in Wuppertal, Germany, and lay off 350 workers. Its recombinant factor VIII production will take place at its site in Berkeley, California. The cuts in Germany come on top of the announced layoffs in October of more than 225 manufacturing workers in Berkeley.

Bayer will also let go of its animal health unit, get rid of the Coppertone and Dr. Scholl’s consumer lines and let go 12,000 employees, many in its home country.

Click here to read the entire article.